Publicaciones en las que colabora con Luis Jesús Jiménez Borreguero (15)

2021

  1. Activation of amino acid metabolic program in cardiac HIF1-alpha-deficient mice

    iScience, Vol. 24, Núm. 2

2018

  1. Ablation of the stress protease OMA1 protects against heart failure in mice

    Science Translational Medicine, Vol. 10, Núm. 434

  2. The effect of tissue-segmented attenuation maps on PET quantification with a special focus on large arteries

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 2, pp. 94-102

2017

  1. Could NLRP3-Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients?

    Antioxidants and Redox Signaling, Vol. 27, Núm. 5, pp. 269-275

  2. Retraction: Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence

    Nature communications

2016

  1. Accurate quantification of atherosclerotic plaque volume by 3D vascular ultrasound using the volumetric linear array method

    Atherosclerosis, Vol. 248, pp. 230-237

  2. Myocardial VHL-HIF Signaling Controls an Embryonic Metabolic Switch Essential for Cardiac Maturation

    Developmental Cell, Vol. 39, Núm. 6, pp. 724-739

2015

  1. Cardiovascular imaging: What have we learned from animal models?

    Frontiers in Pharmacology, Vol. 6, Núm. OCT

  2. Erratum: Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence (Nature Communications 6:6473 DOI: 10.1038/ncomms7473 (2015))

    Nature Communications

  3. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2

    Journal of the American College of Cardiology, Vol. 65, Núm. 14, pp. 1438-1450

  4. Magnetic resonance imaging of the atherosclerotic mouse aorta

    Methods in Molecular Biology (Humana Press Inc.), pp. 387-394

  5. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study

    Circulation, Vol. 131, Núm. 24, pp. 2104-2113

2014

  1. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes

    Basic Research in Cardiology, Vol. 109, Núm. 4

2013

  1. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy

    Nature Medicine, Vol. 19, Núm. 2, pp. 193-201

  2. The progression and early detection of subclinical atherosclerosis (PESA) study: Rationale and design

    American Heart Journal, Vol. 166, Núm. 6, pp. 990-998